With an income increase of 333.15% in the fourth quarter 2025, year on year to cumulative value of $359 million, and with 365 employees, Galapagos Nv's income per employee grew on trailing twelve month basis to $ 984,630, this marks a new company high for all of 365 employees.
The Healthcare sector has seen employees of 22 other companies achieving higher income per employee. While Galapagos Nv's total ranking has deteriorated compared to the previous quarter from 0 to 268.

What is Income per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Net Income per Employee▼

None ▼

Net Income per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GLPG Net Income per Employee	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Net Income Change	333.15 %	-	-	-	-65.01 %
Net Income per Employee (TTM) $	984,630	227,320	227,320	227,320	227,320
GLPG's Total Ranking	# 268	# 0	#	#	#
Seq. Net Income Change	-	-	-	-	-

GLPG Company Profile >> Back to GLPG Efficiency Comparisons >> Compare GLPG Net Income per Employee to its Competitors

GLPG Net Income per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 23
Healthcare Sector	# 35
Overall Market	# 268

Net Income per Employee Statistics
High	Average	Low
$ 984,630	$ -9,812	$ -937,228
(Dec 31 2025)		(Dec 31 2020)

Companies with similar Income per Employee for 12 month ending Dec 31 2025, within Healthcare Sector	Income per Employee	Income 12 month ending Dec 31 2025	Number of Employees Dec 31 2025
Innoviva Inc	1,705,440.25	$ 271.165 Million	159
Compugen Ltd	1,683,000.00	$ 35.343 Million	21
Exelixis Inc	1,502,856.15	$ 1,723.776 Million	1,147
Novo Nordisk A	1,473,764.48	$ 102,434.000 Million	69,505
Zevra Therapeutics Inc	1,364,409.84	$ 83.229 Million	61
Xoma Royalty Corporation	1,322,571.43	$ 18.516 Million	14
Glucotrack Inc	1,292,533.33	$ 19.388 Million	15
Q32 Bio Inc	1,242,541.67	$ 29.821 Million	24
Pulmatrix Inc	1,205,500.00	$ 2.411 Million	2
Capsovision Inc	1,195,050.51	$ 118.310 Million	99
Catalyst Pharmaceuticals Inc	1,177,615.38	$ 214.326 Million	182
Theravance Biopharma inc	1,176,611.11	$ 105.895 Million	90
Coherus Oncology inc	1,143,020.41	$ 168.024 Million	147
Argenx Se	1,125,466.03	$ 1,292.035 Million	1,148
Tg Therapeutics Inc	1,120,749.37	$ 447.179 Million	399
Rafael Holdings Inc	1,119,000.00	$ 25.737 Million	23
Keros Therapeutics Inc	1,115,564.10	$ 87.014 Million	78
Black Diamond Therapeutics Inc	1,065,095.24	$ 22.367 Million	21
Galapagos Nv	984,630.36	$ 359.390 Million	365
United Therapeutics Corporation	953,357.14	$ 1,334.700 Million	1,400
Silexion Therapeutics Corp	850,857.14	$ 11.912 Million	14
Prestige Consumer Healthcare Inc	795,059.65	$ 453.184 Million	570
Petros Pharmaceuticals inc	787,672.33	$ 2.363 Million	3
Heartflow Inc	773,161.33	$ 651.775 Million	843
Chemomab Therapeutics Ltd	749,583.33	$ 8.995 Million	12
Halozyme Therapeutics Inc	749,146.57	$ 316.889 Million	423
Traws Pharma inc	731,294.12	$ 12.432 Million	17
Krystal Biotech Inc	694,342.37	$ 204.831 Million	295
Ptc Therapeutics inc	688,843.59	$ 682.644 Million	991
Elite Pharmaceuticals Inc	667,834.38	$ 43.409 Million	65

Date modified: 2026-07-07T11:24:58+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.